Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1996
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032482A1 Bacteriocins
10/17/1996WO1996032481A1 New chemokine expressed in eosinophils
10/17/1996WO1996032478A1 Altered polypeptides with increased half-life
10/17/1996WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996WO1996032417A1 Antibodies against heart muscle actin
10/17/1996WO1996032416A1 Novel anti-aids immunotoxins
10/17/1996WO1996032413A1 Process for the purification of glycoproteins like erythropoietin
10/17/1996WO1996032407A1 Igf-i purification process
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032127A1 Methods of enhancing epithelial cell proliferation
10/17/1996WO1996023066A3 Prostaglandin receptor, dp
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996WO1996016173A3 Modified proteinase inhibitors
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217901A1 Phycobilisomes, derivatives, and uses therefor
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2216210A1 Novel anti-aids immunotoxins
10/16/1996EP0737752A2 Fermentation media and methods for controlling norleucine content in polypeptides
10/16/1996EP0737743A1 Thymidine kinase-lacking ouabain-resistant chicken hybridoma
10/16/1996EP0737690A2 Antihypertensive agent and method for preparing same
10/16/1996EP0737314A1 Novel uses for gal4-receptor constructs
10/16/1996EP0737312A1 Analytical device and immunoassay with an internal control of protein a
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
10/16/1996EP0737246A1 BACTERIAL STRAINS OF GENUS $i(BACILLUS) CLOSELY PHENOTYPICALLY RELATED TO GENUS $i(LACTOBACILLUS), CULTURE METHOD AND USE
10/16/1996EP0737209A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133598A Acylated insulin
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133342A Antikanamycin gene originated from microbe
10/16/1996CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565349 Isolated from slime molds; useful in removing dipeptides from n-terminus of genetically engineered peptides
10/15/1996US5565337 High fusion tendency, fused with b-cells to produce hybridomas which have increased resistance to death
10/15/1996US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/15/1996US5565330 Method for removing N-terminal dipeptides from precursor polypeptides with dipeptidylaminopeptidase from Dictyostelium discoideum
10/15/1996US5565323 Determination of mutations in sequence of mitochrondial cytochrome oxidase genes which indicate presence or risk of alzheimer*s disease
10/15/1996US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
10/15/1996CA1338642C Bacterial methionine n-terminal peptidase
10/14/1996CA2174025A1 Agents modulating the response of neuronal cells to inhibition by mammalian central nervous system myelin
10/10/1996WO1996031780A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031611A1 Novel promoters for expressing proteins of interest in yeast
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031606A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031602A1 Retroviral vectors
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031521A1 Inhibiting degradation of a degron-bearing protein
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996DE19512937A1 Neuer Inhibitor des Erythrina caffra Typs und dessen Verwendung zur Reinigung von Serinproteasen New inhibitor of Erythrina caffra type and its use for the purification of serine proteases
10/10/1996CA2218405A1 Novel promoters for expressing proteins of interest in yeast
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217491A1 Polynucleotide immunogenic agents
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996CA2216880A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/09/1996EP0736605A1 Process for producing proteins
10/09/1996EP0736602A2 Siaalpha 2,3Ga1beta 1, 4G1cNAc alpha 2,8-sialyltransferase
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736542A1 Peptides that induce antibodies which inhibit HIV-type retroviruses and antibodies specific for these peptides
10/09/1996EP0736180A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
10/09/1996EP0736106A1 Methods of screening for beta-amyloid peptide production inhibitors
10/09/1996EP0736102A1 Method for preparing peptide products, and resulting products
10/09/1996EP0736101A1 Enzymatic method for synthesis of o-glycosylated amino acid or peptide or derivatives thereof
10/09/1996EP0736099A1 Expression of self-processing polyproteins in transgenic plants
10/09/1996EP0736096A1 Antimicrobial proteins
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736088A1 Monoclonal antibodies to hepatitis e virus and methods for using same
10/09/1996EP0736087A1 Monoclonal antibodies against hev orf-2 and methods for using same
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0528928B1 Interleukin-4 binding protein-gamma
10/09/1996CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis
10/09/1996CN1133049A Melanona-inhibiting protein
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 1125